Lincoln Pharmaceuticals Limited has informed the Exchange about change in Management
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Manubhai Hargovandas Patel, General Manager - Engineering & Maintenance at Lincoln Pharmaceuticals, has resigned citing personal reasons, effective July 8, 2025, after close of business hours. The role was designated as Senior Management Personnel under SEBI LODR regulations. The company has submitted the resignation letter along with the required Annexure A disclosures to NSE and BSE. This is a routine operational-level personnel change with no disclosed successor named in the filing.
This is a mid-level operational departure and is unlikely to have any material impact on the company's financials, strategy, or stock price. Investors need not take any action as the role is functional in nature (engineering and maintenance).